 |
|
|
|
 |
A Phase III Study of Conventional Whole Breast Irradiation Versus Partial Breast Irradiation for Women with Early-Stage Breast Cancer
[Protocol 05-068]
- Full Title :
- A RANDOMIZED PHASE III STUDY OF CONVENTIONAL WHOLE BREAST IRRADIATION (WBI) VERSUS PARTIAL BREAST IRRADIATION (PBI) FOR WOMEN WITH STAGE 0, I, OR II BREAST CANCER (RTOG 0413) (NSABP B-39)
- Purpose :
Studies have shown that giving radiation therapy to the breast after a lumpectomy helps keep breast cancer from returning. Whole breast irradiation (WBI) is a standard treatment after a lumpectomy, given 5 days a week for 5 to 7 weeks to the entire breast. Partial breast irradiation (PBI) is given only to the area of the breast where the cancer was removed. PBI is given twice a day over a period of 5 to 10 days.
Early studies suggest that PBI may work as well as WBI. The purpose of this study is to see if PBI is as effective as WBI for preventing breast cancer recurrence. Researchers will also determine if the way the breast looks after PBI is as good as after WBI. Patients will be asked how they feel about how their breasts look after surgery and radiation therapy.
- Eligibility :
To be eligible for this study, patients must meet several criteria, including but not limited to the following:
- Patients must have stage 0, I, or II breast cancer that was or will be removed with lumpectomy.
- Patients may not have had prior radiation therapy, chemotherapy, or biological therapy prior to entering the study. Hormonal therapy is permitted as long as the duration of treatment did not exceed 28 days after breast cancer diagnosis.
- Patients must be age 18 or older.
For more information and to see if you are eligible for this study, please contact Dr. Beryl McCormick or Dr. Kathryn Beal at 212-639-6828.
|
|
|
|
|
